Home

KEYNOTE SPEAKERS

Matthew R. Galeotti, JD

Head, Criminal Division, US Department of Justice; Author, DOJ Memorandum: Focus, Fairness, and Efficiency in the Fight Against White-Collar Crime, Washington, DC

Mary E. Riordan, JD

Senior Counsel to the Inspector General, Inspector General, US Department of Health and Human Services, Washington, DC

Amy L. Bedsaul

Open Payments Communications, Data Analytics & Systems Group, Centers for Medicare & Medicaid Services, Baltimore, MD

Veronika Peleshchuk Fradlin, MA

Director of Division of Transparency Projects, Centers for Medicare and Medicaid Services, Baltimore, MD

Charlene Keller Fullmer, JD

Assistant US Attorney and Deputy Chief Civil Division, US Attorney’s Office, Eastern District of Pennsylvania, US Department of Justice; Former Attorney Advisor, FBI, Philadelphia, PA

Abraham George, JD

Assistant US Attorney and Chief, Civil Division, US Attorney Office, District of Massachusetts, Boston, MA

Mackenzie Queenin, JD

Assistant US Attorney and Chief, Health Care Fraud, US Attorney Office, District of Massachusetts; Adjunct Professor, Boston College of Law, Boston, MA

FEATURED FACULTY

Andrew Blasi, MBA

Founder & CEO, Ethicist Intl; Founding Member, Anti-Corruption Leaders Hub, OECD; Faculty, Intl Anti-Corruption Academy, Washington, DC

Tess Carey, PharmD

Senior Pharmacist, Clinical Strategy, Amazon Pharmacy, Philadelphia, PA

Virginia MacSuibhne, JD

The Compliance Fairy Godmother; Executive Director, Legal Compliance, Alumis; Former VP & Global CCO, Agilent Technologies, Santa Clara, CA

Ida Nassar, JD

Vice President, Assistant General Counsel, Ethics &Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, Drug Enforcement Administration, Washington, DC

Spencer Stiles, MBA

Group President, Orthopaedics, Stryker; Director, Chart Industries; Director, Medical Device Manufacturers Association; Director, Business Leaders for Michigan, Kalamazoo, MI

Julie Ritchie Wagner, JD

Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Washington, DC

ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL

Aisha M. Ghazi Babar, LLB, LLM

General Counsel, Chief Compliance Officer & Corporate Secretary, Pierre Fabre; Former GC & CCO,, Navigate BioPharma Services, Secaucus, NJ

Rachel Batykefer

Vice President, CIA & Compliance Operations, Mallinckrodt; Former Sr. Director, Global Compliance & Ethics Training, Teva, Philadelphia, PA

Peter Brensilver, JD

Senior Vice President, Chief Global Commercial Compliance and Risk Counsel, Pfizer, New York, NY

Terra Buckley, JD

Chief Compliance Officer, LivaNova; Former VP & Head of Compliance, Mesoblast, Summit, NJ

Sri Burra, MBA

Director, US Ethics and Compliance, Organon; Former Ethics & Compliance Lead, North America, Haleon, Malvern, PA

Briana Cabrera, MS, CFE

Senior Director, Global Privacy & Compliance Investigations, Medtronic; Former Director, Forensic Audit, Covidien, Miami, FL

Reanna Carver, JD

Assistant General Counsel, Accord BioPharma, Raleigh, NC

Shoshanna Clark, JD

Vice President, Ethics & Compliance, Kailera Therapeutics; Former Vice President, Chief Compliance Officer, Cerevel Therapeutics, Boston, MA

Steven Cohen, MBA

Vice President, Chief Ethics and Compliance Officer, North America, Eli Lilly, Fishers, IN

Thomas Daly, JD

Associate Director, Compliance, Biocon Biologics, Bridgewater, NJ

Brian Danahy, JD

Deputy General Counsel and Chief Compliance Officer, Exactech; Former, Compliance Program Manager, Zimmer, Gainesville, FL

Evan DaSilva, CPA, CFE, CAMS

US Business Ethics Monitoring & Operations, Ipsen Biopharmaceuticals, Boston, MA

David J. Derusha, JD

Compliance Director, Vertex Pharmaceuticals; Former Assistant US Attorney, US Attorney’s Office, District of Massachusetts, Boston, MA

Sarah diFrancesca, JD

Executive Director of Compliance, Dermatology, Incyte, Wilmington, DE

Edgar H. Donohoe, JD

Vice President & Lead Compliance Counsel, Pfizer US, New York, NY

Margaret K. Feltz, MA, JD

Vice President, Chief Compliance Officer, Purdue Pharma LP; Former Co-chair, PCF, Stamford, CT

Jeanille Gatta, MA

Director, Compliance Business Partner, AstraZeneca, North America, Philadelphia, PA

Patrick Gibson, JD

Former Associate Vice President, Global Compliance Counseling, Organon; Former Special Assignment — Global Compliance Separation Lead, Merck, Villanova, PA

Kate Godfrey, JD, CCEP

Senior Vice President, Global Chief Compliance Officer, Karl Storz, US; Former VP, Chief Compliance and Privacy Officer, Veracyte, Inc., Seattle, WA

Asha Green, JD, MPA, CCEP, CHC

Director, US Compliance, Ferring; Former Global Head, I&C Risk Assessment & Mitigation Planning, Indivior, Parsippany NJ

Ayushman Hazarika, CA, MBA, CFE

Managed Markets Finance, Novartis; Former US SEC and Management Reporting, Merck and Schering-Plough, Berkeley Heights, NJ

Tom Hiney, JD, CIPP/US, CIPM

Privacy Counsel and Senior Director, Blueprint Medicines, Boston, MA

Peter Jensen, JD

Vice President, Global Chief Compliance Officer, Arthrex; Former Chief Nominations Counsel, US Senate Judiciary Committee, Naples, FL

Abe Kassis, PhD

Senior Director, Global Head Compliance and Legal Operations, Bausch + Lomb; Former Global Compliance – Director of Compliance, New York, NY

Joseph E. Keeney, JD

Head of Ethics and Compliance, Galderma Laboratories; Former Sr. Director/Head of Healthcare Compliance, Organogenesis, Dallas, TX

Jonathon L. Kellerman

Global Chief Ethics, Compliance and Privacy Officer & Global Head of Business Transformation, Bausch + Lomb; Former Executive Vice President & Global Chief Compliance Officer, Allergan, Bridgewater, NJ

Sara Kimball, JD

Assistant General Counsel, Daiichi Sankyo, Basking Ridge, NJ

Angelique Lee, JD

Former Vice President, Chief Compliance and Ethics Officer, Jazz Pharmaceuticals; Former VP, Global CCO, Greenwich Biosciences, San Juan Capistrano, CA

Jeff Lemay, JD

Executive Director, N.A. Compliance Officer, Jazz; Former Sr. Director, US Compliance Officer, Greenwich Bioscience, Carlsbad, CA

Aaron Lewis, MBA

Director, Legal and Compliance Operations, Cordis; Former Director, Compliance Insights and Technologies, Cardinal Health, Columbus, OH

Jill Mason, JD

Chief Compliance and Risk Officer, Orthofix; Former Senior Global Compliance Director, St. Jude Medical, Dallas, TX

Jenny McVey, MS, PhD

Former North America Compliance Officer, bioMerieux; Adjunct Professor, Fordham University School of Law, Salt Lake City, UT

Kelley Medeiros, MPH

Compliance Officer, Neuromodulation; Compliance Officer, LivaNova; Former Global & US Oncology Compliance Officer, EMD Serono, Boston, MA

Nereida Parks, MBA, MPH, JD

Privacy, AI and HIPAA Officer, OAC, Olympus Medical; Former Regional Privacy Officer, North America and Specialty Care, Sanofi, Westborough, MA

Richard Perry, MEd

Compliance Operations Manager, Incyte; Board Member, William Way LGBT Community Center; Former Corporate Compliance Specialist, Adaptimmune, Wilmington, DE

Erica (Owen) Powers

Vice President, Chief Compliance Officer, Sage Therapeutics; Former Director Corporate Compliance, Vertex, Boston, MA

Omar Richardson, MBA

Senior Director of Compliance, Shionogi; Former Compliance Officer, Grünenthal; Former Director, Corporate Compliance, Indivior, New York, NY

Patrick Santiago, MBA, CIPM

Director, Global Data Privacy, Genmab; Former Associate Director, US Data Privacy Operations, Boehringer Ingelheim, Plainsboro, NJ

Monica Schroeter, CPA, CISA

Head of Compliance Operations and Risk, LivaNova; Former Head of Compliance, F2G, Summit, NJ

Elizabeth Smith, JD

Senior Director, G&A Contracts and Data Privacy, Exelixis; Former Head of Global Privacy, Senior Director and Associate General Counsel, Privacy Law, Seagen, Louisville, KY

Emily Treanor, JD

Head of Global Investigations and Enterprise Risk Management, Alnylam Pharmaceuticals, Washington, DC

Kelly J. Tope, JD, MBA

Head, Ethics and Business Integrity Governance, Operations & Risk Mgmt, Sanofi; Former Head, USBU Ethics & Compliance Monitoring & Reporting Operations, Takeda, Boston, MA

Sarah Whipple, JD

Vice President, Global Chief Compliance Officer, Apellis; Former VP, Legal & Chief Compliance Officer, Akebia; Former VP, Global Compliance & Privacy Officer, Aegerion, Boston, MA

Susan Williamson, MBA

Senior Vice President & Chief Compliance Officer, Endo; Former Senior Manager, WBB Finance, Operational Risk Management, Pfizer, Malvern, PA

Matt Zebley

Senior Manager, Compliance, Transparency and HCP Engagement, Incyte Corporation, Wilmington, DE

FORMER SENIOR GOVERNMENT OFFICIALS

Jennifer Bragg, JD

Partner, Latham and Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US Food and Drug Administration, Washington, DC

Greg Demske, JD

Partner, Goodwin Procter; Former Chief Counsel, Office of Inspector General, US Department of Health and Human Services, Washington, DC

Jacob T. Elberg, JD

Director, Center for Pharma Law, Seton Hall School of Law; Former AUSA, US Attorney’s Office, District of New Jersey, Newark, NJ

Sarah A. Franklin, JD

Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling, LLP; Former Attorney, US Federal Trade Commission, Washington, DC

Gejaa T. Gobena, JD

Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

Paul Joseph, JD

Senior Director, Counsel, Eli Lilly; Former Associate Chief Counsel for Enforcement, US FDA; Former Senior Trial Attorney, Criminal Division, US DOJ, Potomac, MD

John Kelly, JD

Partner and Chair, Healthcare Industry Practice, Barnes & Thornburg; Former Assistant Chief for Health Care Fraud, Criminal Division, Fraud Section, US Department of Justice, Washington, DC

Joshua S. Levy, JD

Partner, Ropes & Gray LLP; Former US Attorney for the District of Massachusetts, Boston, MA

Allan Medina, JD

Partner, Goodwin Procter; Former Senior Deputy Chief, Criminal Division, US Department of Justice, Washington, DC

Michael L. Shaw, JD

Global Head, Compliance, Privacy & Risk, ZS; Former VP & CO, GlaxoSmithKline; Former Senior Counsel, HHS OIG, Princeton, NJ

OTHER FEATURED FACULTY

David Amendola

Director, ResEcon Life Sciences & Healthcare; Former Global Compliance Risk Evaluation and Management, ConvaTec, New York, NY

Eliza L. Andonova, JD

Partner Global Life Science Regulatory, Hogan Lovells, Washington, DC

Michelle D. Axelrod, JD

Principal, Porzio, Bromberg & Newman; Former Assistant General Counsel, Sunovion, Westborough, MA

Samantha Barrett Badlam, JD

Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC

Yogesh Bahl, MBA

Partner and Leader, Life Sciences and Healthcare Practice, ResEcon Life Sciences & Healthcare; CFO, IACTA Pharma, New York, NY

Brett Barlag, MBA

Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY

Craig Bleifer, JD

Partner, Health Care & Life Sciences, McGuireWoods; Former Corporate VP, GC, Novo Nordisk, New York, NY

Eric Bolesh

Chief Executive Officer, Cutting Edge Information, Durham, NC

Eve M. Brunts, JD, LLM

Partner, Ropes & Gray, Boston, MA